Larry Z. Shen

Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus

Orville Kolterman, Dennis Dong Hwan Kim, Larry Z. Shen et al. · American Journal of Health-System Pharmacy · 2005 · 438 citations

Pharmacy, Pharmacokinetics, Pharmacology +7

Continual Reassessment Method: A Likelihood Approach

John O’Quigley, Larry Z. Shen · Biometrics · 1996 · 376 citations

Computing, Biostatistics, Bayesian Biostatistics +9

Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes

Mark Fineman, Thomas A. Bicsak, Larry Z. Shen et al. · Diabetes Care · 2003 · 355 citations · Full text

Medicine, Endocrinology, Pharmacology +17

DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks

John B. Buse, Daniel J. Drucker, Kristin Taylor et al. · Diabetes Care · 2010 · 354 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trial

Robert E. Ratner, Richard A. Dickey, Mark Fineman et al. · Diabetic Medicine · 2004 · 307 citations

Medicine, Endocrinology, Pharmacotherapy +17